The goal of this in vitro study was to evaluate the effectiveness of a new surface disinfectant consisting of an antimicrobial metabolic substrate containing silver ions stabilized in citric acid (AMS), compared to traditional disinfectants used in the dental office.
Methods: The evaluation was performed by simulating nebulization, as performed in the clinic, on different surfaces. The experiment was carried out in a microbiology laboratory using a laminar flow hood. The test product (AMS) was compared with eight different disinfectants containing molecules such as quaternary ammoniums and alcohols, the gold standard in the decontamination process. The bacterial and fungi strains, grown in Muller Hinton broth and in Sabouraud broth, were Escherichia coli, Staphylococcus aureus and Candida albicans.
The spray nebulization of 0.8–1 ml of suspension containing a bacterial load (104 cells/ml) on plastic (Petri dishes) and glass surfaces (slides) and a negative control group evaluation (NN) were carried out. After drying, the contaminated surfaces were sprayed again (2–3 sprays), each with only one disinfectant except the plates and glass surfaces for the negative control plates (NN). Each disinfectant was allowed to act for about 2 minutes.
The evaluation of bacterial residues was carried out through the counting of the colony forming units (CFU) using contact slides and contact plates, which are used in clinical routine in microbiological laboratories to evaluate the bacterial load present on contaminated surfaces. The test was performed three times for each disinfectant and for each bacterial/fungal strain. Once sampling was performed using contact plates and contact slides, the same were placed in the incubator for 24 hours and the following day the colony forming units (CFU) were counted.
Results: The bacterial and Candida albicans counts obtained were 0 for most of the disinfectants tested. In the first series of tests, 102 CFU of Escherichia coli were found on AMS contact plates and 41 CFU of Candida albicans were found on contact slides treated with an alcohol-based disinfectant (G). In the second and third series of tests, however, the number of CFU was reduced to 0 for all disinfectant agents. In the negative control group, on the other hand, CFUs of all microorganisms were found on the contact plates and contact slides.
Conclusion: In this in vitro study, the AMS-based surface disinfectant appeared as effective as other alcohols and/or quaternary ammonium compounds. However, considering the reduced toxicity of AMS compared to traditional molecules, its daily use could be considered preferable. Further studies will be useful to confirm the efficacy of this active ingredient.
Clinical significance:
Natural, non-toxic and non-caustic molecules such as AMS could be used as an alternative to active ingredients that are widely used in the daily disinfection of work surfaces, reducing the amount of toxic compounds to which healthcare workers are exposed.
Oral Hygiene & Prevention 03 June 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Oral Hygiene & Prevention 20 May 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Oral Hygiene & Prevention 06 May 2026
This peer-reviewed oral hygiene & prevention article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment...
Prevention of dental caries and periodontal disease for people with special needs is a challenging problem in dentistry.
Oral Hygiene & Prevention 08 April 2026
Periodontal regeneration of infrabony defects (V). Effect of oral hygiene on long‐term stability
The aim of this investigation was to assess the role of supportive periodontal care in the maintenance of clinical attachment gained, after surgical treatment according to the principles of GTR, in...
New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.
News 05 June 2026
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
News 05 June 2026
(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will
As the University of Colorado School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose exceptional de
Oral surgery 05 June 2026
This peer-reviewed oral surgery article summarizes clinical evidence from International journal of oral and maxillofacial surgery (2026). It focuses on findings that may help dental professionals...